Brain Mechanisms of the Placebo Effect: An Affective Appraisal Account

Annual Review of Clinical Psychology

Volumn 13, Issue , 2017, Pages 73-89

  Ashar, Yoni K ^a   Chang, Luke J ^b   Wager, Tor D ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Dartmouth College   (United States)

Author keywords

Default mode; Emotion; Expectation; Mood disorders; Pain; Parkinson's disease

Indexed keywords

ANALGESIA; ARTICLE; ASSOCIATION; BEHAVIOR; BRAIN FUNCTION; CLINICAL OUTCOME; COGNITION; EMOTION; HUMAN; PAIN; PERSONAL VALUE; PLACEBO EFFECT; SELF CONCEPT; SELF EVALUATION; SELF FOCUSED COGNITION; BRAIN; MENTAL DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

BRAIN; EMOTIONS; HUMANS; MENTAL DISORDERS; PLACEBO EFFECT;

EID: 85019166403     PISSN: 15485943     EISSN: 15485951     Source Type: Book Series    
DOI: 10.1146/annurev-clinpsy-021815-093015     Document Type: Article

References (186)

1. Amanzio M, Benedetti F, Porro CA, Palermo S, Cauda F. 2013. Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain. Hum. Brain Mapp. 34:738-52
2. Amodio DM, Frith CD. 2006. Meeting of minds: the medial frontal cortex and social cognition. Nat. Rev. Neurosci. 7:268-77
3. Andrews-Hanna JR, Smallwood J, Spreng RN. 2014. The default network and self-generated thought: component processes, dynamic control, and clinical relevance. Ann. N. Y. Acad. Sci. 1316:29-52
4. Atlas LY, Wager TD. 2014. A meta-analysis of brain mechanisms of placebo analgesia: consistent findings and unanswered questions. In Placebo, ed. by F Benedetti, pp. 37-69. Berlin: Springer
5. Atlas LY, Whittington RA, Lindquist MA,Wielgosz J, Sonty N, Wager TD. 2012. Dissociable influences of opiates and expectations on pain. J. Neurosci. 32:8053-64
6. Bandelow B, ReittM, Röver C, Michaelis S, Görlich Y, Wedekind D. 2015. Efficacy of treatments for anxiety disorders: a meta-analysis. Int. Clin. Psychopharmacol. 30:183-89
7. Bannuru RR, McAlindon TE, Sullivan MC,Wong JB, Kent DM, Schmid CH. 2015. Effectiveness and implications of alternative placebo treatments: a systematic review and network meta-analysis of osteoarthritis trials. Ann. Int. Med. 163:365-72
8. Barrett LF. 2012. Emotions are real. Emotion 12:413-29
9. Barrett LF. 2014. The conceptual act theory: a précis. Emot. Rev. 6:292-97
10. Bartra O, McGuire JT, Kable JW. 2013. The valuation system: a coordinate-based meta-analysis of BOLD fMRI experiments examining neural correlates of subjective value. NeuroImage 76:412-27
11. Benedetti F. 2014. Placebo effects: from the neurobiological paradigm to translational implications. Neuron 84:623-37
12. Benedetti F, Amanzio M, Vighetti S, Asteggiano G. 2006. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J. Neurosci. 26:12014-22
13. Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, et al. 2004. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat. Neurosci. 7:587-88
14. Benedetti F, Frisaldi E, Carlino E, Giudetti L, Pampallona A, et al. 2016. Teaching neurons to respond to placebos. J. Physiol. 594:5647-60
15. Benedetti F, Maggi G, Lopiano L, Lanotte M. 2003a. Open versus hidden medical treatments: The patient's knowledge about a therapy affects the therapy outcome. Prev.Treat. 6. https://dx.doi.org/10.1037/1522-3736.6.1.61a
16. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. 2003b. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J. Neurosci. 23:4315-23
17. Berntson GG, Micco DJ. 1976. Organization of brainstem behavioral systems. Brain Res. Bull. 1:471-83
18. Berntson GG, Tuber DS, Ronca AE, Bachman DS. 1983. The decerebrate human: associative learning. Exp. Neurol. 81:77-88
19. Berridge KC, Kringelbach ML. 2008. Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology 199:457-80
20. Binder JR, Desai RH, Graves WW, Conant LL. 2009. Where is the semantic system? A critical review and meta-analysis of 120 functional neuroimaging studies. Cereb. Cortex 19:2767-96
21. Blakemore S-J. 2008. The social brain in adolescence. Nat. Rev. Neurosci. 9:267-77
22. Büchel C, Geuter S, Sprenger C, Eippert F. 2014. Placebo analgesia: a predictive coding perspective. Neuron 81:1223-39
23. Buckner RL, Carroll DC. 2007. Self-projection and the brain. Trends Cogn. Sci. 11:49-57
24. Carew TJ, Hawkins RD, Kandel ER. 1983. Differential classical conditioning of a defensive withdrawal reflex in Aplysia californica. Science 219:397-400
25. Carlino E,Torta D, Piedimonte A, Frisaldi E, Vighetti S, Benedetti F. 2014. Role of explicit verbal information in conditioned analgesia. Eur. J. Pain 19:546-53
26. Chib VS, Rangel A, Shimojo S, O'Doherty JP. 2009. Evidence for a common representation of decision values for dissimilar goods in human ventromedial prefrontal cortex. J. Neurosci. 29:12315-20
27. Colloca L, Lopiano L, Lanotte M, Benedetti F. 2004. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 3:679-84
28. Colloca L, Miller FG. 2011. How placebo responses are formed: a learning perspective. Philos. Trans. R. Soc. Lond. B Biol. Sci. 366:1859-69
29. Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. 2010. How the number of learning trials affects placebo and nocebo responses. Pain 151:430-39
30. Colloca L, Sigaudo M, Benedetti F. 2008a.The role of learning in nocebo and placebo effects. Pain 136:211-18
31. Colloca L, Tinazzi M, Recchia S, Le Pera D, Fiaschi A, et al. 2008b. Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain 139:306-14
32. Constantinescu AO, O'Reilly JX, Behrens TE. 2016. Organizing conceptual knowledge in humans with a gridlike code. Science 352:1464-68
33. Craggs JG, Price DD, PerlsteinWM, Verne NG, Robinson ME. 2008. The dynamic mechanisms of placebo induced analgesia: evidence of sustained and transient regional involvement. Pain 139(3):660-69
34. Craggs JG, Price DD, Robinson ME. 2014. Enhancing the placebo response: functional magnetic resonance imaging evidence of memory and semantic processing in placebo analgesia. J. Pain 15(4):435-46
35. Crum AJ, Corbin WR, Brownell KD, Salovey P. 2011. Mind over milkshakes: mindsets, not just nutrients, determine ghrelin response. Health Psychol. 30:424-29; discussion 430-31
36. Cuijpers P, Driessen E, Hollon SD, van Oppen P, Barth J, Andersson G. 2012. The efficacy of non-directive supportive therapy for adult depression: a meta-analysis. Clin. Psychol. Rev. 32:280-91
37. Jong PJ, van Baast R, Arntz A, Merckelbach H. 1996. The placebo effect in pain reduction: the influence of conditioning experiences and response expectancies. Int. J. Behav. Med. 3:14-29
38. Fuente-FernándezR,RuthTJ, Sossi V, SchulzerM, CalneDB, Stoessl J. 2001. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293:1164-66
39. Denny BT, Kober H,Wager TD, Ochsner KN. 2012. A meta-analysis of functional neuroimaging studies of self-and other judgments reveals a spatial gradient for mentalizing in medial prefrontal cortex. J. Cogn. Neurosci. 24:1742-52
40. DoellerCF, Barry C, BurgessN. 2010. Evidence for grid cells in a human memory network. Nature 463:657-61
41. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, et al. 2009a. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63:533-43
42. Eippert F, Finsterbusch J, Bingel U, Buchel C. 2009b. Direct evidence for spinal cord involvement in placebo analgesia. Science 326:404
43. Ellsworth PC, Scherer KR. 2003. Appraisal processes in emotion. In Handbook of Affective Sciences, ed. RJ Davidson, KR Scherer, HH Goldsmith, pp. 572-95. Oxford, UK: Oxford Univ. Press
44. Enck P, Benedetti F, Schedlowski M. 2008. New insights into the placebo and nocebo responses. Neuron 59:195-206
45. Etkin A, Egner T, Kalisch R. 2011. Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn. Sci. 15:85-93
46. Etkin A, Wager TD. 2007. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am. J. Psychiatry 164:1476-88
47. Fässler M, Meissner K, Kleijnen J, Hróbjartsson A, Linde K. 2015. A systematic review found no consistent difference in effect between more and less intensive placebo interventions. J. Clin. Epidemiol. 68:442-51
48. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. 2010. Biological, clinical, and ethical advances of placebo effects. Lancet 375:686-95
49. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, et al. 2010. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 303:47-53
50. Frank JD, Frank JB. 1993. Persuasion and Healing: A Comparative Study of Psychotherapy. Baltimore, MD: Johns Hopkins Univ. Press
51. Freeman EW, Ensrud KE, Larson JC, Guthrie KA, Carpenter JS, et al. 2015. Placebo improvement in pharmacologic treatment of menopausal hot flashes. Psychosom. Med. 77(2):167-75
52. Frith CD, Frith U. 2006. The neural basis of mentalizing. Neuron 50:531-34
53. Fuentes J, Armijo-Olivo S, Funabashi M, Miciak M, Dick B, et al. 2014. Enhanced therapeutic alliance modulates pain intensity and muscle pain sensitivity in patientswith chronic low back pain: an experimental controlled study. Phys. Ther. 94(4):477-89
54. Gaston L, Marmar CR, Gallagher D, Thompson LW. 1989. Impact of confirming patient expectations of change processes in behavioral, cognitive, and brief dynamic psychotherapy. Psychotherapy 26:296-302
55. Geuter S, Eippert F, Hindi Attar C, Büchel C. 2013. Cortical and subcortical responses to high and low effective placebo treatments. NeuroImage 67:227-36
56. Goebel MU, Trebst AE, Steiner J, Xie YF, Exton MS, et al. 2002. Behavioral conditioning of immunosuppression is possible in humans. FASEB J. 16:1869-73
57. Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, et al. 2008. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov. Disord. 23:690-99
58. Gottfried JA, O'Doherty J, Dolan RJ. 2003. Encoding predictive reward value in human amygdala and orbitofrontal cortex. Science 301:1104-7
59. Grau JW. 2014. Learning from the spinal cord: how the study of spinal cord plasticity informs our view of learning. Neurobiol. Learn. Mem. 108:155-71
60. Gu X, Lohrenz T, Salas R, Baldwin PR, Soltani A, et al. 2015. Belief about nicotine selectively modulates value and reward prediction error signals in smokers. PNAS 112(8):2539-44
61. Gu X, Lohrenz T, Salas R, Baldwin PR, Soltani A, et al. 2016. Belief about nicotine modulates subjective craving and insula activity in deprived smokers. Front. Psychiatry 7:126. https://doi.org/10.3389/ fpsyt.2016.00126
62. Guo JY, Yuan XY, Sui F, Zhang WC, Wang JY, et al. 2011. Placebo analgesia affects the behavioral despair tests and hormonal secretions in mice. Psychopharmacology 217:83-90
63. Gusnard D, Akbudak E, Shulman GL, Raichle ME. 2001. Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function. PNAS 98:4259-64
64. Gusnard DA, Raichle ME. 2001. Searching for a baseline: functional imaging and the resting human brain. Nat. Rev. Neurosci. 2:685-94
65. Hardy GE, Barkham M, Shapiro DA, Reynolds S, Rees A, Stiles WB. 1995. Credibility and outcome of cognitive-behavioural and psychodynamic-interpersonal psychotherapy. Br. J. Clin. Psychol. 34:555-69
66. Hare T, O'Doherty J, Camerer C, SchultzW, Rangel A. 2008. Dissociating the role of the orbitofrontal cortex and the striatum in the computation of goal values and prediction errors. J. Neurosci. 28:5623-30
67. Hashmi JA, Baria AT, Baliki MN, Huang L, Schnitzer TJ, Apkarian AV. 2012. Brain networks predicting placebo analgesia in a clinical trial for chronic back pain. Pain 153:2393-402
68. Herrnstein RJ. 1962. Placebo effect in the rat. Science 138:677-78
69. Hróbjartsson A, Gøtzsche PC. 2010. Placebo interventions for all clinical conditions. Cochrane Database Syst. Rev. 20:CD003974
70. Izquierdo A, Suda RK,Murray EA. 2004. Bilateral orbital prefrontal cortex lesions in rhesus monkeys disrupt choices guided by both reward value and reward contingency. J. Neurosci. 24:7540-48
71. Jenkins AC, Macrae CN,Mitchell JP. 2008. Repetition suppression of ventromedial prefrontal activity during judgments of self and others. PNAS 105:4507-12
72. Jenkins AC, Mitchell JP. 2011. Medial prefrontal cortex subserves diverse forms of self-reflection. Soc. Neurosci. 6:211-18
73. Jepma M, Wager TD. 2015. Conceptual conditioning: mechanisms mediating conditioning effects on pain. Psychol. Sci. 26:1728-39
74. JonasWB, Crawford C, Colloca L, KaptchukTJ, MoseleyB, et al. 2015.Towhat extent are surgery and invasive procedures effective beyond a placebo response? A systematic review with meta-analysis of randomised, sham controlled trials. BMJ Open 5:e009655
75. Joyce AS, PiperWE. 1998. Expectancy, the therapeutic alliance, and treatment outcome in short-term individual psychotherapy. J. Psychother. Pract. Res. 7:236-48
76. Kahn I, Andrews-Hanna JR, Vincent JL, Snyder AZ, Buckner RL. 2008. Distinct cortical anatomy linked to subregions of the medial temporal lobe revealed by intrinsic functional connectivity. J. Neurophysiol. 100:129-39
77. Kaiser RH, Andrews-Hanna JR,Wager TD, Pizzagalli DA. 2015. Large-scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity. JAMA Psychiatry 72:603-11
78. Kam-Hansen S, Jakubowski M, Kelley JM, Kirsch I, Hoaglin DC, et al. 2014. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci. Transl. Med. 6:218ra5
79. Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, et al. 2010. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLOS ONE 5:e15591
80. Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, et al. 2008. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 336:999-1003
81. Kazdin AE, Krouse R. 1983. The impact of variations in treatment rationales on expectancies for therapeutic change. Behav. Ther. 14:657-71
82. Keay K, Bandler R. 2001. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci. Biobehav. Rev. 25:669-78
83. Kelley WM, Macrae CN, Wyland CL, Caglar S, Inati S, Heatherton TF. 2002. Finding the self? An eventrelated fMRI study. J. Cogn. Neurosci. 14:785-94
84. Kessner S, Forkmann K, Ritter C, Wiech K, Ploner M, Bingel U. 2014. The effect of treatment history on therapeutic outcome: psychological and neurobiological underpinnings. PLOS ONE 9:e109014
85. Kessner S, Wiech K, Forkmann K, Ploner M, Bingel U, et al. 2013. The effect of treatment history on therapeutic outcome: an experimental approach. JAMA Intern. Med. 173:1468-69
86. Khan A, Faucett J, Lichtenberg P, Kirsch I, Brown WA. 2012. A systematic review of comparative efficacy of treatments and controls for depression. PLOS ONE 7:e41778
87. Khan A, Kolts RL, Rapaport MH, Krishnan KR, Brodhead AE, Brown WA. 2005. Magnitude of placebo response and drug-placebo differences across psychiatric disorders. Psychol. Med. 35:743-49
88. Khan A, Redding N, Brown WA. 2008. The persistence of the placebo response in antidepressant clinical trials. J. Psychiatr. Res. 42:791-96
89. Kim HF, Hikosaka O. 2013. Distinct basal ganglia circuits controlling behaviors guided by flexible and stable values. Neuron 79:1001-10
90. Kirsch I. 1985. Response expectancy as a determinant of experience and behavior. Am. Psychol. 40:1189-202
91. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. 2008. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLOS Med. 5:e45
92. Ko JH, Feigin A, Mattis PJ, Tang CC, Ma Y, et al. 2014. Network modulation following sham surgery in Parkinson's disease. J. Clin. Investig. 124:3656-66
93. Koban L, Ruzic L, Wager TD. 2013. Brain predictors of individual differences in placebo responding. In Placebo and Pain, ed. L Colloca, MA Flaten, K Meissner, pp. 89-102. Boston: Acad. Press
94. Koban L, Wager TD. 2016. Beyond conformity: social influences on pain reports and physiology. Emotion 16:24-32
95. Kong J, Spaeth R, Cook A, Kirsch I, Claggett B, et al. 2013. Are all placebo effects equal? Placebo pills, sham acupuncture, cue conditioning and their association. PLOS ONE 8:e6748
96. Krishnan A,Woo C-W, Chang LJ, Ruzic L, Gu X, et al. 2016. Somatic and vicarious pain are represented by dissociable multivariate brain patterns. eLife 5:e15166
97. Lazarus RS, Folkman S. 1984. Stress, Appraisal, and Coping. New York: Springer
98. Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. 2002. Changes in brain function of depressed subjects during treatment with placebo. Am. J. Psychiatry 159:122-29
99. Liberman RP. 1967. The elusive placebo reactor. Neuro-Psycho-Pharmacology: Proc. Int. Congr. Coll. Int. Neuro-Psycho-Pharmacol., 5th, Washington, DC, pp. 557-66. Amsterdam/New York: Excerpta Medica
100. Lidstone SC. 2010. Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch. Gen. Psychiatry 67:857-65
101. Lieberman MD, Jarcho JM, Berman S, Naliboff BD, Suyenobu BY, et al. 2004. The neural correlates of placebo effects: a disruption account. NeuroImage 22(1):447-55
102. Lindquist KA, Satpute AB, Wager TD, Weber J, Barrett LF. 2016. The brain basis of positive and negative affect: evidence from a meta-analysis of the human neuroimaging literature. Cereb. Cortex 26:1910-22
103. Lindquist KA,Wager TD, Kober H, Bliss-Moreau E, Feldman Barrett L. 2012. The brain basis of emotion: a meta-analytic review. Behav. Brain Sci. 35:121-43
104. Madsen MV, Gotzsche PC, Hrobjartsson A. 2009. Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups. BMJ 338:a3115
105. Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, et al. 2010. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 9:1164-72
106. MasonMF, Norton MI, Van Horn JD, Wegner DM, Grafton ST, Macrae CN. 2007. Wandering minds: the default network and stimulus-independent thought. Science 315:393-95
107. Matsumoto M, Hikosaka O. 2009. Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature 459:837-41
108. Mayberg HS. 2002. The functional neuroanatomy of the placebo effect. Am. J. Psychiatry 159(5):728-37. http://doi.org/10.1176/appi.ajp.159.5.728
109. Mechias M-L, Etkin A, Kalisch R. 2010. A meta-analysis of instructed fear studies: implications for conscious appraisal of threat. NeuroImage 49:1760-68
110. Meissner K. 2011. The placebo effect and the autonomic nervous system: evidence for an intimate relationship. Philos. Trans. R. Soc. Lond. B Biol. Sci. 366:1808-17
111. Meissner K, Distel H, Mitzdorf U. 2007. Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials. BMC Med. 5:3
112. Meissner K, Fässler M, Rücker G, Kleijnen J, Hróbjartsson A, et al. 2013. Differential effectiveness of placebo treatments. JAMA Intern. Med. 173:1910-41
113. Meyer B, Yuen KSL, Ertl M, Polomac N, Mulert C, et al. 2015. Neural mechanisms of placebo anxiolysis. J. Neurosci. 35:7365-73
114. Meyer ML, Spunt RP, Berkman ET, Taylor SE, Lieberman MD. 2012. Evidence for social working memory from a parametric functional MRI study. PNAS 109:1883-88
115. Milad M, Quirk G. 2002. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420:70-74
116. Mitchell JP,Macrae CN, BanajiMR. 2006. Dissociable medial prefrontal contributions to judgments of similar and dissimilar others. Neuron 50:655-63
117. Moerman DE, Jonas WB. 2002. Deconstructing the placebo effect and finding the meaning response. Ann. Intern. Med. 136:471-76
118. Montgomery GH, Kirsch I. 1997. Classical conditioning and the placebo effect. Pain 72:107-13
119. Morelli SA, Sacchet MD, Zaki J. 2015. Common and distinct neural correlates of personal and vicarious reward: a quantitative meta-analysis. NeuroImage 112:244-53
120. Morelli SA, Torre JB, Eisenberger NI. 2014. The neural bases of feeling understood and not understood. Soc. Cogn. Affect. Neurosci. 9:1890-96
121. Morrison SE, Saez A, Lau B, Salzman CD. 2011. Different time courses for learning-related changes in amygdala and orbitofrontal cortex. Neuron 71:1127-40
122. Morton DL, Watson A, El-Deredy W, Jones AKP. 2009. Reproducibility of placebo analgesia: effect of dispositional optimism. Pain 146:194-98. https://doi.org/10.1016/j.pain.2009.07.026
123. Moseley JB, O'Malley K, Petersen NJ, Menke TJ, Brody BA, et al. 2002. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N. Engl. J. Med. 347:81-88
124. Müller M, Kamping S, Benrath J, Skowronek H, Schmitz J, Klinger R, Flor H. 2016. Treatment history and placebo responses to experimental and clinical pain in chronic pain patients. Eur. J. Pain 1-12. http://doi.org/10.1002/ejp.877
125. Nakamura Y, Donaldson GW, Kuhn R, Bradshaw DH, Jacobson RC, Chapman CR. 2012. Investigating dose-dependent effects of placebo analgesia: a psychophysiological approach. Pain 153:227-37
126. Olanow WC, Bartus RT, Baumann TL, Factor S, Boulis N, et al. 2015. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: a double-blind, randomized, controlled trial. Ann. Neurol. 78:248-57
127. Ortony A, Clore GL, Collins A. 1988. The Cognitive Structure of Emotions. New York: Cambridge Univ. Press
128. Padoa-Schioppa C. 2011. Neurobiology of economic choice: a good-basedmodel. Annu. Rev. Neurosci. 34:333-59
129. Papakostas GI, Fava M. 2009. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials inMDD.Eur. Neuropsychopharmacol. 19:34-40
130. Pauli WM, O'Reilly RC, Yarkoni T, Wager TD. 2016. Regional specialization within the human striatum for diverse psychological functions. PNAS 113:1907-12
131. Peci na M, Bohnert ASB, Sikora M, Avery ET, Langenecker SA, et al. 2015. Association between placeboactivated neural systems and antidepressant responses. JAMA Psychiatry 72:1087-94
132. Plassmann H, Wager TD. 2014. How expectancies shape consumption experiences. In The Interdisciplinary Science of Consumption, ed. SD Preston, ML Kringelbach, B Knutson, pp. 219-40. Cambridge, MA: MIT
133. Posternak MA, Zimmerman M, Keitner GI, Miller IW. 2002. A reevaluation of the exclusion criteria used in antidepressant efficacy trials. Am. J. Psychiatry 159:191-200. https://doi.org/10.1176/appi.ajp. 159.2.191
134. Pressman A, Avins AL, Neuhaus J, Ackerson L, Rudd P. 2012. Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST). Contemp. Clin. Trials 33:492-98
135. Price DD, Finniss DG, Benedetti F. 2008. A comprehensive review of the placebo effect: recent advances and current thought. Annu. Rev. Psychol. 59:565-90
136. Price JL. 1999. Prefrontal cortical networks related to visceral function and mood. Ann. N. Y. Acad. Sci. 877:383-96
137. Quessy SN, Rowbotham MC. 2008. Placebo response in neuropathic pain trials. Pain 138:479-83
138. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. 2001. A default mode of brain function. PNAS 98:676-82
139. Rakel D, Barrett B, Zhang Z, Hoeft T, Chewning B, et al. 2011. Perception of empathy in the therapeutic encounter: effects on the common cold. Patient Educ. Couns. 85(3):390-97
140. Robinson MJF, Berridge KC. 2013. Instant transformation of learned repulsion into motivational "wanting." Curr. Biol. 23:282-89
141. Rogers TB, Kuiper NA, Kirker WS. 1977. Self-reference and the encoding of personal information. J. Pers. Soc. Psychol. 35:677-88
142. Roy M, Shohamy D, Wager TD. 2012. Ventromedial prefrontal-subcortical systems and the generation of affective meaning. Trends Cogn. Sci. 16:147-56
143. Rudebeck PH, Murray EA. 2014. The orbitofrontal oracle: cortical mechanisms for the prediction and evaluation of specific behavioral outcomes. Neuron 84(6):1143-45
144. Rudebeck PH, Saunders RC, Prescott AT, Chau LS, Murray EA. 2013. Prefrontal mechanisms of behavioral flexibility, emotion regulation and value updating. Nat. Neurosci. 16(8):1140-45
145. Rutherford BR. 2016. Patient expectancy as a mediator of placebo effects in antidepressant clinical trials. Am. J. Psychiatry 174:135-42
146. Rutherford BR, Bailey VS, Schneier FR, Pott E, Brown PJ, Roose SP. 2015. Influence of study design on treatment response in anxiety disorder clinical trials. Depress. Anxiety 32:944-57
147. Rutherford BR, Pott E, Tandler JM,Wall MM, Roose SP, Lieberman JA. 2014. Placebo response in antipsychotic clinical trials: a meta-analysis. JAMA Psychiatry 1032:1409-21
148. Schafer SM, Colloca L, Wager TD. 2015. Conditioned placebo analgesia persists when subjects know they are receiving a placebo. J. Pain 16:412-20
149. Schedlowski M, Pacheco-Lopez G. 2010. The learned immune response: Pavlov and beyond. Brain Behav. Immun. 24:176-85
150. Scherer KR. 2001. Appraisal considered as a process of multilevel sequential checking. In Appraisal Processes in Emotion: Theory, Methods, Research, ed. KR Scherer, A Schorr, T Johnstone, pp. 92-120. Oxford, UK/ New York: Oxford Univ. Press
151. Schmidt L, Braun EK, Wager TD, Shohamy D. 2014. Mind matters: placebo enhances reward learning in Parkinson's disease. Nat. Neurosci. 17:1793-97
152. Scott DJ, Stohler CS, Egnatuk CM,Wang H, Koeppe RA, Zubieta J-K. 2008. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch. Gen. Psychiatry 65:220-31
153. Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, et al. 2010. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? J. Clin. Psychiatry 71:270-79
154. Smith CA, Ellsworth PC. 1985. Patterns of cognitive appraisal in emotion. J. Pers. Soc. Psychol. 48:813-38
155. Sneed JR, Rutherford BR, Rindskopf D, Lane DT, Sackeim HA, Roose SP. 2008. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am. J. Geriatr. Psychiatry 16:65-73
156. Sorokin I, Schatz A, Welliver C. 2015. Placebo medication and sham surgery responses in benign prostatic hyperplasia treatments: implications for clinical trials. Curr. Urol. Rep. 16(10). 16-73. https://doi.org/ 10.1007/s11934-015-0544-4
157. Sotsky SM, Glass DR, Shea MT, Pilkonis PA, Collins JF, et al. 1991. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. Am. J. Psychiatry 148:997-1008
158. Stalnaker TA, Cooch NK, Schoenbaum G. 2015. What the orbitofrontal cortex does not do. Nat. Neurosci. 18:620-27
159. Stewart-Williams S, Podd J. 2004. The placebo effect: dissolving the expectancy versus conditioning debate. Psychol. Bull. 130:324-40
160. Strunk DR, DeRubeis RJ, Chiu AW, Alvarez J. 2007. Patients' competence in and performance of cognitive therapy skills: relation to the reduction of relapse risk following treatment for depression. J. Consult. Clin. Psychol. 75(4):523-30
161. Tétreault P, Mansour A, Vachon-Presseau E, Schnitzer TJ, Apkarian AV, Baliki MN. 2016. Brain connectivity predicts placebo response across chronic pain clinical trials. PLOS Biology 14(10):e1002570
162. Tremblay L, SchultzW. 1999. Relative reward preference in primate orbitofrontal cortex. Nature 398:704-8
163. Tuttle AH, Tohyama S, Ramsay T, Kimmelman J, Schweinhardt P, et al. 2015. Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. Pain 156:2616-26
164. Van Overwalle F. 2009. Social cognition and the brain: a meta-analysis. Hum. Brain Mapp. 30:829-58
165. Vase L, Riley JL, Price DD. 2002. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99:443-52
166. Vase L, Robinson ME, Verne GN, Price DD. 2005. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioidmechanisms. Pain 115:338-47
167. Vincent JL, Snyder AZ, FoxMD, ShannonBJ, Andrews JR, et al. 2006. Coherent spontaneous activity identifies a hippocampal-parietal memory network. J. Neurophysiol. 96:3517-31
168. Volkow ND, Wang G-J, Ma Y, Fowler JS, Zhu W, et al. 2003. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J. Neurosci. 23:11461-68
169. Volkow ND, Wang G, Fowler JS, Tomasi D, Telang F, et al. 2011. Addiction: beyond dopamine reward circuitry. PNAS 108(37):15037-42
170. Wager TD, Atlas LY. 2015. The neuroscience of placebo effects: connecting context, learning and health. Nat. Rev. Neurosci. 16:403-18
171. Wager TD, Atlas LY, Leotti LA, Rilling JK. 2011. Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. J. Neurosci. 31:439-52
172. Wager TD, Fields HL. 2013. Placebo analgesia. In Textbook of Pain, ed. S McMahon, M Koltzenburg, I Tracey, DC Turk, pp. 362-73. Philadelphia: Elsevier Health Sci.
173. Wager TD, Kang J, Johnson TD, Nichols TE, Satpute AB, Barrett LF. 2015. A Bayesian model of categoryspecific emotional brain responses. PLOS Comput. Biol. 11:e1004066
174. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, et al. 2004. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 303:1162-67
175. Wager TD, Scott DJ, Zubieta J-K. 2007. Placebo effects on human μ-opioid activity during pain. PNAS 104:11056-61
176. Wagner DD, Kelley WM, Haxby JV, Heatherton TF. 2016. The dorsal medial prefrontal cortex responds preferentially to social interactions during natural viewing. J. Neurosci. 36:6917-25
177. Wallis JD. 2007. Orbitofrontal cortex and its contribution to decision-making. Annu. Rev. Neurosci. 30:31-56
178. Wampold BE, Imel ZE. 2015. The Great Psychotherapy Debate: The Evidence for What Makes PsychotherapyWork. New York: Routledge. 2nd ed
179. Wechsler ME, Kelley JM, Boyd IOE, Dutile S, Marigowda G, et al. 2011. Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N. Engl. J. Med. 365:119-26
180. Wendt L, Albring A, Ober K, Engler H, Freundlieb C, et al. 2013. Placebo-induced immunosuppression in humans: role of learning and expectation. Brain Behav. Immun. 29(Suppl):S17
181. Whalley B, Hyland ME, Kirsch I. 2008. Consistency of the placebo effect. J. Psychosom. Res. 64:537-41
182. Wilson-Mendenhall CD, Barrett LF, Simmons WK, Barsalou LW. 2011. Grounding emotion in situated conceptualization. Neuropsychologia 49:1105-27
183. Woods SC, Ramsay DS. 2000. Pavlovian influences over food and drug intake. Behav. Brain Res. 110:175-82
184. Woods SW, Gueorguieva RV, Baker CB, Makuch RW. 2005. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia. Arch. Gen. Psychiatry 62:961-70
185. Yarkoni T, Poldrack RA, Nichols TE, Van Essen DC, Wager TD. 2011. Large-scale automated synthesis of human functional neuroimaging data. Nat. Methods 8:665-70
186. Yeo BTT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D, et al. 2011. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J. Neurophysiol. 106:1125-65